EUVIMEDEUVIMED entdecken
Crossref

Association of lipid‐lowering agent use and dry eye disease: A nationwide matched case–control study in Taiwan, 2002–2016

Li-Nien Chien iD, Yun-I Chou, Yuan-Jen Tsai, Li-Chin Sung, Hung-Yi Liu, Meng-Yin Lin, Tsung-Jen Wang, I-Chan Lin iD

Acta Ophthalmologica · 2023

DOI: 10.1111/aos.15656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, 2023. Verfasst von Li-Nien Chien und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Welfare Policy, National Yang Ming Chios Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Dry Eye Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study is to evaluate the association between lipid‐lowering agent use and the risks of diagnosed dry eye disease (DED).

Methods

This retrospective, case–control study included 780 786 patients who received lipid‐lowering agents in 2002–2016, of which 17 409 were newly diagnosed with DED during a ≥2‐year follow‐up period. These patients were matched 1:4 with control participants for age, sex, and comorbidities. Separate odds ratios (OR) were calculated for DED and each of statin and fibrate use.

Results

Statin users had significantly higher odds of DED (adjusted OR = 1.12; 95% confidence interval (CI) = 1.08–1.16, p < 0.0001) than nonusers. Fibrate users did not show higher odds of DED than nonusers (adjusted OR = 1.04; 95% CI = 0.99–1.10, p = 0.125). The lipophilic statin users did not show higher odds of DED compared with the hydrophilic statin users (adjusted OR = 0.99, 95% CI = 0.93–1.06, p = 0.729). Among statin users, the odds of DED did not differ significantly between patients receiving statin therapy for >180 days vs. ≤90 days or patients receiving statin therapy for 91–180 days vs. ≤90 days (adjusted OR = 1.00, p = 0.922; adjusted OR = 0.94, p = 0.541, respectively). The odds of DED were not statistically different among patients receiving low‐intensity, moderate‐intensity, and high‐intensity of statin therapy.

Conclusions

Patients receiving statin therapy had a higher DED risk than patients not receiving statin therapy. The type of statin, the duration, and the intensity of statin use were not significantly associated with DED risks. Further studies are required to identify the relevant factors related to DED risks with statin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDry Eye SyndromesHumansCase-Control StudiesRetrospective StudiesTaiwanLipidsFibric AcidsRisk Factors

Stichwörter der Autor:innen

dry eye diseasefibrateshyperlipidaemialipid-lowering agentstatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsLipidsFibric Acids

Autor:innen und Institutionen

  • Institute of Health and Welfare Policy, National Yang Ming Chios Tung University, Taipei, Taiwan.
  • Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.
  • Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

ORCID-Profile: Li-Nien Chien, I-Chan Lin

Zitieren

APA

Chien, L. N., Chou, Y. I., Tsai, Y. J., Sung, L. C., Liu, H. Y., Lin, M. Y., Wang, T. J., & Lin, I. C. (2023). Association of lipid‐lowering agent use and dry eye disease: A nationwide matched case–control study in Taiwan, 2002–2016. Acta Ophthalmologica. https://doi.org/10.1111/aos.15656

Vancouver

Chien LN, Chou YI, Tsai YJ, Sung LC, Liu HY, Lin MY, et al. Association of lipid‐lowering agent use and dry eye disease: A nationwide matched case–control study in Taiwan, 2002–2016. Acta Ophthalmologica. 2023. doi:10.1111/aos.15656

BibTeX
@article{Chien2023,
  author = {Chien, Li-Nien and Chou, Yun-I and Tsai, Yuan-Jen and Sung, Li-Chin and Liu, Hung-Yi and Lin, Meng-Yin and Wang, Tsung-Jen and Lin, I-Chan},
  title = {Association of lipid‐lowering agent use and dry eye disease: A nationwide matched case–control study in Taiwan, 2002–2016},
  journal = {Acta Ophthalmologica},
  year = {2023},
  doi = {10.1111/aos.15656}
}
Kostenlos starten →